Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Anthony R. Lanfranco

Dr. Anthony R. Lanfranco

Director, Bronchoscopy Program

Dr. Anthony R. Lanfranco is an interventional pulmonologist with the much-acclaimed Mesothelioma and Pleural Diseases Program at Penn Medicine in Philadelphia.

Get in touch
Jump to a Topic:

About Anthony R. Lanfranco

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Top Doctor icon

    Top Doctor

  • Team Leader icon

    Team Leader

  • 10+ Years of Experience icon

    10+ Years of Experience

  • Works for Specialty Center icon

    Works for Specialty Center

Lanfranco plays a key role in the diagnosis and staging of pleural mesothelioma — an often difficult task — and helping to determine a patient’s course of treatment.

He works alongside medical oncologists, radiation oncologists, thoracic surgeons and pathologists in the multidisciplinary approach that has worked so well for patients at the Abramson Cancer Center.

Much of his work involves diseases of the lungs and a variety of respiratory issues.

As an interventional pulmonologist, he has expertise in several minimally-invasive procedures:

  • A pleurodesis removes excess fluid buildup around the lungs and can prevent future pleural effusions.

  • A thoracoscopy examines the pleural lining of the lungs.

  • A bronchoscopy is another tool commonly used for both therapeutic and diagnostic purposes.

“When we see patients in our office, one of the biggest things we confront is uncertainty,” Lanfranco said. “There are questions. ‘Am I going to be OK? How could this happen to me?’ We, as a group, try to mediate that by providing timely interventions.”

Wearing Many Hats

Lanfranco is the director of bronchoscopy at Penn Presbyterian Medical Center. He also is the director of the Interventional Pulmonary Fellowship Program and associate program director of the Pulmonary and Critical Care Fellowship, sharing his expertise with medical students.

He is currently an investigator in a clinical trial at Penn Medicine assessing a new technique to examine lung nodules in patients at risk for lung cancer.

“A lot is happening today in the field of interventional pulmonology, taking it from diagnostics and staging to treatment modalities,” Lanfranco said.

One of his other roles today is addressing complications stemming from chemotherapy and radiation.

He has board certification in internal medicine and pulmonary disease. At Penn Medicine, he is involved in the Lung Cancer and Lung Nodule programs, along with the Medical Critical Care Program.

He also has clinical expertise in smoking-related diseases, hemoptysis, emphysema, atelectasis and tracheal stenosis.

Lanfranco is a member of the American College of Chest Physicians, the American Thoracic Society and the Association of Interventional Pulmonology Program Directors.

He received his medical degree from Drexel University in Philadelphia. He completed his residency at Thomas Jefferson University Hospital and his fellowship at the Hospital of the University of Pennsylvania.

Disclaimer: Dr. Anthony R. Lanfranco has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Daniel King, Content Writer for
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. (2019, January 29). Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions.
    Retrieved from:
  2. Penn Medicine. (n.d.). Anthony R. Lanfranco, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 24, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now